510(k) Report

510(k) · Cleared

Cleared

Nessi Otc Spacer

K101532510(k) TraditionalCleared Sep 1, 201090-day reviewClass II21 CFR 868.5630

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Pharmacaribe · NVO Spacer, Direct Patient Interface

Cleared on Sep 1, 2010 as substantially equivalent to K091862 (Pharmacaribe, 2009) after a 90-day review. Its family tree reaches back 2 generations to 2001.

Decided
Sep 1, 2010
Review
90 days
Class
Class II
Product code
NVO
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K010680 (2001). 3 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 2007: 1 other ancestorK010680 · CT Spacer · Clinical Technologies, Inc. · 2001K091862 · Nessi Spacer · Pharmacaribe · 20092000200220042006200820102012
Other ancestors, by generation 2 generations back: 1 other ancestor K091862 · Nessi Spacer · Pharmacaribe · 2009K010680 · CT Spacer · Clinical Technologies, Inc. · 20010
  1. Root · 2 generations backK010680 CT SpacerClinical Technologies, Inc. · 2001
  2. 1 generation backK091862 Nessi SpacerPharmacaribe · 2009
  3. This deviceK101532 Nessi Otc SpacerPharmacaribe · 2010
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K010680CT SpacerClinical Technologies, Inc.2001—
−1K091862Nessi SpacerPharmacaribe2009—
0 (this device)K101532Nessi Otc SpacerPharmacaribe2010—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200710
FIG. 1 — Lineage of K101532, 2001–2010Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NVO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K091862Nessi Spacer
Summary page 4
…Holding Chambers, Direct Patient Interface NVO - CFR 868.5630 Predicate Devices: K091862 – PharmaCaribe NESSI (Rx) Spacer Primatene Mist – OTC MDI Device Description: The N…
Pharmacaribe2009—
*—Primatene Mist – OTC MDI
Named without a submission number
—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 9 years and passes through 2 companies; a new generation was cleared every 8.5 years on median.
  • None of the 3 ancestors has a recall.

How does its category compare?

All NVO devices

NVO Spacer, Direct Patient Interface: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.

FDA decisions per year · NVO

1in 2010

2009: 12010: 1
2007high 1 (2009) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NVO

Too few NVO 510(k)s in any year since 2007 to give a median.

Recalls per year · NVO

No recall names NVO since 2007.

Adverse event reports per year · NVO

No MAUDE report names NVO since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20091—00
20101—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

The NESSI OTC Spacer is intended to be used to administer aerosolized medication from pressurized Metered-Dose Inhalers, which are over-the-counter (OTC), e.g., bronchodilator / epinephrine.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K101532: Nessi Otc Spacer.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K101532

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026